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Abstract

Background
Dyskerin, which is an important component of the telomerase complex and is needed for normal
telomerase activity, is frequently overexpressed in neoplasia. Dyskerin also plays an essential role in
ribosome biogenesis. Since protein synthesis increases during tumorigenesis, this led us to hypothesize
that dyskerin expression would be upregulated independently of the cell immortalization mechanism.

Methods
Dyskerin and telomerase reverse transcriptase (TERT) expression were examined in oral squamous cell
carcinomas (OSCC) and patient-matched controls, and in a panel of telomerase-positive and telomerasenegative cells. Antisense inhibition of TERT was used to test the effects of downregulation of telomerase
on dyskerin expression.

Results
Dyskerin was frequently overexpressed in OSCC and in immortalized and transformed keratinocytes
relative to primary cells, independently of TERT and telomerase activity. Instead, dyskerin expression
strongly correlated with cell proliferation rates.

Conclusions
The role of dyskerin in tumorigenesis does not correlate with its function within the telomerase complex.
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Background—Dyskerin, which is an important component of the telomerase complex and is
needed for normal telomerase activity, is frequently overexpressed in neoplasia. Dyskerin also
plays an essential role in ribosome biogenesis. Since protein synthesis increases during
tumorigenesis, this led us to hypothesize that dyskerin expression would be upregulated
independently of the cell immortalization mechanism.
Methods—Dyskerin and telomerase reverse transcriptase (TERT) expression were examined in
oral squamous cell carcinomas (OSCC) and patient-matched controls, and in a panel of
telomerase-positive and telomerase-negative cells. Antisense inhibition of TERT was used to test
the effects of downregulation of telomerase on dyskerin expression.
Results—Dyskerin was frequently overexpressed in OSCC and in immortalized and transformed
keratinocytes relative to primary cells, independently of TERT and telomerase activity. Instead,
dyskerin expression strongly correlated with cell proliferation rates.
Conclusions—The role of dyskerin in tumorigenesis does not correlate with its function within
the telomerase complex.
Keywords
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INTRODUCTION
Telomeres are specialized nucleoprotein structures that cap and protect the ends of
eukaryotic chromosomes, thereby preserving genomic integrity.1 To extend cellular
replicative lifespan, human tumors use either one of two mechanisms for telomere
maintenance. The most common is mediated by the telomerase ribonucleoprotein (RNP)
complex which replicates telomeres through the addition of a variable number of
hexanucleotide TTAGGG repeats to the chromosome ends.2-4 The other mechanism is the
telomerase-independent, alternative lengthening of telomeres (ALT) pathway which
mediates telomere replication by homologous DNA recombination; the exact mechanisms
remain poorly understood.5
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Telomerase activity is undetectable in most somatic cells except for those that are highly
regenerative and undergo constant self-renewal, including oral keratinocytes. However,
upregulation of telomerase activity is common to most forms of neoplasia, including
80-90% of oral squamous cell carcinomas (OSCC); telomerase levels increase early in oral
carcinogenesis.3 In contrast, only a small subset of tumors, and only rarely OSCC and other
head and neck squamous cell carcinomas, use the ALT mechanism for telomere
homeostasis.6
The telomerase RNP has two core components, including telomerase reverse transcriptase
(TERT), which is the catalytic subunit, and telomerase RNA (TERC), which is the template
used to prime telomere replication.4 But several additional factors are also required for full
activity of the complex, including dyskerin (encoded by the DKC1 gene), which directly
binds to and stabilizes TERC within the complex.2,7,8
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Dyskerin is a highly conserved and vital, 58 kDa nucleolar RNA binding protein that is
required for the biogenesis of a subtype of RNP.7,9 Together with three other conserved
factors, dyskerin forms a core complex that binds non-coding H/ACA RNA, including
TERC and subsets of small nucleolar RNA (snoRNA) and Cajal body RNA.9 There are over
100 known human H/ACA RNA, and the specific function of each H/ACA RNP is
dependent on the RNA that it incorporates. Loss of dyskerin function reduces steady-state
levels of TERC, decreases telomerase activity and leads to premature telomere shortening.
7,8 However, dyskerin has also been shown to play important roles in ribosome biogenesis
and function. Through binding to H/ACA snoRNA, dyskerin is required for posttranscriptional processing of precursor rRNA.10,11 A recent report suggests that dyskerin
also regulates translation of a subset of mRNAs via an internal ribosome entry site.12 Thus,
dyskerin is a key component of two molecular pathways that are fundamentally important to
the tumor cell phenotype; neoplasms require not only a mechanism for telomere
homeostasis, but also have a high demand for protein synthesis.4,13 To that end, DKC1
mRNA is frequently and significantly overexpressed in a variety of human cancers,
including lymphoma, melanoma, neuroblastoma, and adenocarcinomas of the breast, colon
and ovary.14-21
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We and others previously demonstrated that human dyskerin expression is increased in
experimental conditions that promote cell growth and proliferation.22-24 Gu et al25 recently
reported that a mutant form of murine dyskerin significantly impaired normal cell
proliferation by a mechanism that was dependent upon the presence of a functional
telomerase complex. They observed that in the absence of either Tert or Terc, the dyskerinmutant and wild-type cells grew similarly. However, it is unknown if dyskerin also requires
an active telomerase complex in order to exert its influence in human cells.
In this study, we investigated the dependency of the interaction between dyskerin and
telomerase in human cells and during tumorigenesis. TERT expression is commonly used as
a surrogate marker for telomerase.26,27 However, we show for the first time that dyskerin
expression is frequently overexpressed in sporadic OSCC, and that upregulation of dyskerin
does not require the presence of TERT or an active telomerase complex. Instead, dyskerin
expression correlates with active cell proliferation.

Methods and Materials
Cell culture
Primary oral keratinocytes OKF4, OKF6, and their respective TERT-immortalized
derivatives, OKF4-TERT1F and OKF6-TERT2 were cultured in Keratinocyte-Serum Free
Media (K-SFM; Invitrogen, Carlsbad, CA) supplemented with 25 μg/ml bovine pituitary
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extract, 0.2 ng/ml epidermal growth factor, and 0.4 mM CaCl2. OKF4 and OKF6 cells and
their TERT-derivatives have been well-characterized.28 These cells originate from the
normal oral epithelium of two distinct individuals. K-SFM is not designed to grow cells to
high density. Thus, to enable us to expand the cultures to densities high enough for our
assays, cells were plated in rapid growth media composed of a 1:½:½ mix of K-SFM:
calcium-free, glutamine-free Dulbecco's minimal essential mediun (DMEM; Invitrogen):
Ham's F-12 (Invitrogen), supplemented with 0.2 ng/ml epidermal growth factor, 25 μg/ml
bovine pituitary extract, 0.75 mM L-glutamine, and 0.2 mM CaCl2. OKF6-Δp53D1 cells
were grown using Defined K-SFM (Invitrogen) with a pre-formulated growth supplement
supplied by the manufacturer. OKF6-Δp53D1 is a telomerase-negative, ALT-immortalized
derivative of OKF6 and has been previously described.29 The OSCC cell line, UM-SCC-1,
and U2OS human osteosarcoma cells (purchased from American Type Culture Collection,
Manassas, VA) were grown in D-MEM containing high glucose (4,500 μg/mL), 1 mmol/L
of glutamine, and 10% fetal bovine serum. All media formulations were supplemented with
100 IU/mL penicillin and 100 IU/mL streptomycin.
mRNA analysis and quantitation
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Thirteen distinct, fresh frozen OSCC and patient-matched normal oral mucosal tissue
samples were obtained from the University of Pennsylvania Oral, Head and Neck Tumor,
Tissue and Saliva Bank with appropriate informed consent and institutional regulatory
approval. Total RNA was extracted from 20 to 110 mg of tissue using TRIzol Reagent
(Invitrogen, Carlsbad, CA), as per the manufacturer's recommendations. For RNA extraction
from cell lines, we used the Rneasy technique (Qiagen, Valencia, CA). Quantitative RTPCR was performed as previously outlined.22 Quantitect Primer Assays (Qiagen) for
DKC1, TERT, β-actin and Tata binding protein (TBP) were used, respectively. Relative
DKC1 and TERT expression levels, respectively, were normalized to TBP or actin using the
2−ΔΔCT method. For DKC1 and TERT quantitation from the tissue samples, the reactions
were performed three times. For analysis of cellular mRNA expression, three independent
samples were used.
Western blot analysis
Whole cell lysates were extracted as described previously.22 Polyclonal antibodies against
dyskerin, β-actin, GAPDH and secondary antibodies were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA). All Western blot analyses were performed at least three
times. NIH Image J was used to quantitate relative dyskerin expression.
Cell proliferation and cell cycle distribution assays
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Equivalent numbers of cells were seeded and cell proliferation was assessed using the Cell
Proliferation Reagent WST-1 (Roche Applied Science, Indianapolis, IN). Absorbance was
measured using a Multiskan Ascent microplate photometer (ThermoScientific Labsystems,
Hudson, NH). The relative absorbances were measured for up to four days after plating of
the cells. For cell cycle analysis, cells were washed and fixed for at least 60 min with cold
80% ethanol. The cells were then resuspended in 1 mL cold PBS and stained with 10 μg/ml
propidium iodide containing 1 mg/ml RNase A (Sigma-Aldrich) for 30 min. Samples were
analyzed on a Becton-Dickinson FacstarPLUS flow cytometer (BD Biosciences). A minimum
of 5,000 events were collected on each sample; cell cycle analysis was performed using
Modfit (Verity Software House; Topsham, ME).
TERT inhibition and telomerase repeat amplification protocol (TRAP) assay
A TERT antisense DNA oligonucleotide, 5′-TTGAAGGCCTTGCGGACGTG-3′ (TERTANTI) and a control, non-specific oligonucleotide, 5′-TAAGCTGTTCTATGTGTT-3′
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(TERT-CTRL), were synthesized by Invitrogen and prepared as 1 mM stocks in sterile
water. Both molecules were protected by phosphorothioate linkages at their terminal ends
(underlined). The TERT-ANTI and TERT-CTRL sequences were previously described in
studies by Kraemer et al.30
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OKF6-TERT2 cells were seeded in 24 well plates and grown for two days. On the 3rd day,
cells were transfected in quadruplicate with either 10 μM TERT-ANTI or TERT-CTRL
using Lipofectamine 2000 (Invitrogen) as the carrier. Twenty-four hours after transfection,
the cells were pelleted, washed with PBS, and resuspended in ice-cold CHAPS lysis buffer
(0.5% 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate [CHAPS], 0.1 mM
benzamidine, 10% glycerol, 10 mM Tris-HCl, pH 7.5, 1 mM MgCl2, 1 mM EGTA, and 5
mM 2-mercaptoethanol). Total protein concentrations were measured using the BCA Protein
Assay Kit (Thermo Fisher Scientific, Rockford, IL). Five micrograms of each of the
respective protein extracts were then used to assess telomerase activity levels using the
TRAPeze RT Telomerase Detection Kit (Millipore, Billerica, MA) as per the manufacturer's
recommendations. This highly sensitive assay makes use of fluorimetric probes which allow
for real time quantification of telomerase activity. In a parallel set of experiments, the cells
were similarly transfected with the TERT-ANTI and TERT-CTRL oligonucleotides, except
the cells were harvested for total RNA. All transfection experiments were performed twice.
Where indicated, OKF-TERT2 and Δp53D1 cells were harvested in exponential growth
phase and assayed for telomerase activity. However, for illustration purposes, the TRAP
PCR products were resolved on a pre-cast 10% Novex TBE polyacrylamide gel (Invitrogen).
Mutation screening
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Genomic DNA was extracted from each of the thirteen OSCC samples, as previously
described.31 Using previously published primer sets32 with some modifications
(Supplemental Table 1), the complete translated and untranslated regions of the DKC1 gene
were amplified. This included amplification of all 15 exons and associated intron splice
sites. The reaction conditions were: 40-100ng of genomic DNA, 10pmol of each primer;
4-8mM MgCl2, 2mM of each dNTP, 0.5 unit of AmpliTaq Gold DNA Polymerase (Applied
Biosystems, Foster City, CA) and the manufacturer's buffer in a 50μl final volume.
Amplifications were carried out as follows: an initial denaturation for 10min at 95°C
followed by 35 cycles of 94°C for 30s, 55–63°C for 30s, 72°C for 1min, and a final
extension for 10min at 72°C. The annealing temperatures and MgCl2 concentrations were
optimized for each specific primer set. All PCR products were analyzed by agarose gel
electrophoresis, purified using either the QIAQuick PCR Purification Kit or QIAQuick Gel
Extraction Kit (Qiagen), and then sequenced on the ABI PRISM 310 Genetic Analyzer
(Applied Biosystems). Sequencing was done in the sense and anti-sense directions. All
sequence analyses were performed using Sequence Analysis 3.7 and Sequencher 4.0.5
software (Gene Codes Corporation, Ann Arbor, MI).
Correlation of DKC1 and TERT expression in human cell lines
Relative DKC1 and TERT mRNA expression levels were correlated in 93 unique,
transformed human cell lines using the NCI60 on U133A dataset available from the open
access Gene Expression Atlas (http://symatlas.gnf.org/SymAtlas).33 As we previously
described22, we first log transformed the average relative mRNA expression levels for both
genes. Then, we performed a linear regression analysis of the log transformed values,
characterizing DKC1 as the dependent variable and TERT expression as the independent
variable. As controls, we also examined the relationship between DKC1 and MYC, NHP2,
MKI67 and CASP3. All statistical analyses were performed using Sigma Plot 11.0
(SYSTAT Software, San Jose, CA).
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Results
Inhibition of TERT and telomerase activity does not alter dyskerin expression
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Similar to murine cells, it is possible that in normal human cells that exhibit appreciable
levels of telomerase activity, dyskerin expression may be intimately linked to TERT and
telomerase. Moreover, TERT promotes and sustains epithelial proliferation not only by
telomere maintenance, but also by a telomere-independent mechanism through
transcriptional modulation of various growth promoting genes.34,35 A recent study showed
that DKC1 mRNA expression was significantly increased in association with TERT
overexpression in normal human mammary epithelial cells.26 This prompted us to
determine if dyskerin expression was dependent upon TERT in immortalized oral
keratinocytes.
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For these studies, TERT-immortalized human oral keratinocytes (OKF6-TERT2) cells were
transfected with either 10 μM TERT antisense DNA oligonucleotide or a control, nonspecific oligonucleotide. Twenty-four hours after transfection, the cells were harvested, and
telomerase activity levels assayed by quantitative real-time RT-PCR. Due to technical
difficulties, we were unable to reliably assess TERT expression by Western blot. However,
while telomerase levels were decreased by almost 50%, and TERT mRNA expression
reduced by more than 40% relative to the control cells, there was no effect on DKC1 mRNA
expression (Figure 1A, B). Antisense inhibition of TERT in telomerase-positive H1299 lung
adenocarcinoma cells also did not affect DKC1 expression (not shown). Thus, our findings
reinforce those of a previous report which demonstrated no change in dyskerin expression
following antisense inhibition of TERT and telomerase activity in oral cancer cells.2
Dyskerin is upregulated in immortalized keratinocytes independently of telomerase
activity
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Telomerase-positive OKF6-TERT2 and ALT-immortalized OKF6-Δ53D1 cells are derived
from the same parental OKF6 primary oral keratinocyte strain.28,29 OKF6-Δ53D1 cells do
not exhibit telomerase activity and basal TERT mRNA levels are decreased relative to the
parental OKF6 keratinocytes (Figure 1C and not shown; see Ref. 29). However, quantitative
RT-PCR revealed DKC1 mRNA expression to be elevated at least 3-fold in proliferating
OKF6-Δ53D1 and more than 4-fold in OKF6-TERT2 cells relative to OKF6 cells (Figure
1D). Protein expression was also increased approximately 3-fold in the OKF6-Δ53D1 cells
and at least 5-fold in OKF6-TERT2 relative to the primary cells (Figure 1E). We cannot
exclude the possibility that TERT may at least partially contribute to regulation of DKC1
expression in human cells. Nonetheless, these data indicate that upregulation of dyskerin in
immortalized oral keratinocytes is not dependent upon TERT expression or the presence of
telomerase activity.
Dyskerin expression correlates with the rate of active cell proliferation
We and others previously demonstrated that human dyskerin expression is increased in
experimental conditions that promote cell growth and proliferation.22-24 Since dyskerin
contributes to other important cellular processes that are typically upregulated during active
cell growth and proliferation9,11, we next asked if dyskerin expression correlates with the
rate of cell proliferation. For this analysis, we examined two distinct, exponentially-growing
primary oral keratinocyte strains, OKF4 and OKF6, their respective immortalized
derivatives, OKF4-TERT-1F, OKF6-TERT2 and OKF6-Δ53D1, and telomerase-positive
UM-SCC1 oral cancer cells. To our knowledge, there is no ALT-immortalized derivative of
OKF4 cells, and we are not aware of any telomerase-negative oral cancer cell lines. Thus,
we also included the ALT-immortalized U2OS human osteosarcoma cell line in the assay.
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U2OS cells do not express either TERT or TERC and do not exhibit any telomerase activity
(not shown and see Ref. 36).
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The immortalized cells proliferated more rapidly than their primary counterparts, while the
transformed cells were the fastest growing (Figure 2A). Relative dyskerin expression
strongly correlated with cell proliferation rates (r2 = 0.927, p < 0.001) insofar as there was
low basal expression in the slow-growing primary keratinocytes, significantly increased
levels in the immortalized cells and even more so in the transformed cell lines (Figures 2BD). We note that dyskerin expression was greater in OKF6-Δ53D1 cells compared to the
faster-growing OKF4-TERT1F cells (Figure 2D). Moreover, the observation that dyskerin
expression was significantly decreased following contact inhibition of OKF6 and OKF6TERT2 cells reinforces the notion the dyskerin expression is closely associated with active
cell proliferation and not telomerase status (Figures 2D, E and not shown).
DKC1 is upregulated and not mutated in patient-derived OSCC
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Our in vitro studies indicated that dyskerin expression was upregulated in actively
proliferating oral keratinocytes, irrespective of the cell immortalization mechanism.
However, while DKC1 mRNA is significantly overexpressed in several cancer types, its
status in OSCC had not been previously established. Thus, we initially analyzed OSCC
microarray data, a portion of which was previously published in a study aimed at identifying
gene signatures that are predictive of regionally metastatic OSCC.31 In culling the dataset,
we found that DKC1 mRNA expression was significantly upregulated (p < 0.023) in OSCC
(N=49) relative to normal, patient-matched mucosal controls (N=16; Figure 3A).
We then validated DKC1 expression by quantitative RT-PCR in a subset of the tumors and
controls. Of the samples tested, DKC1 mRNA levels were variably increased in 9/13 tumors
(69%, p<0.03) relative to the patient-matched controls (Figure 3B); the transcript was
ubiquitously expressed in all paired samples. Since our sample set was limited, we were
unable to reliably correlate DKC1 expression with any demographic or prognostic variables.

NIH-PA Author Manuscript

Germline mutations in DKC1 give rise to the X-linked recessive form of dyskeratosis
congenita.32,37 This is an unusual disorder associated with a wide-ranging phenotype,
including cancer susceptibility; OSCC is among the most common cancers that these
individuals develop.38 To our knowledge, none of the tumor samples were derived from
individuals with this disorder; most of the patients had classic histories of long-standing
smoking and/or alcohol intake. Nonetheless, we proceeded to analyze the thirteen tumors for
possible DKC1 mutations. Using genomic DNA extracted from each of the tumors, we bidirectionally sequenced all fifteen DKC1 exons and their associated intron splice sites. In
comparing the sequences of the amplicons to those of the known wild-type DKC1 exon
sequences, mutations were not observed in any of the tumors (not shown). However, a
synonymous single nucleotide polymorphism (SNP) was identified in one tumor. This SNP,
Ex14+93G>A, L477L, was confirmed by sequence analysis of the patient-matched normal
tissue sample. While a matched blood sample was not available for further confirmation, this
SNP has been identified in healthy individuals and is not thought to be of any functional or
clinical significance.37,39
Neither protein nor a sufficient amount of fixed tissues were available from any of the
patient samples described above. Thus we used immunohistochemistry to evaluate dyskerin
protein expression from a different series of OSCC and preneoplastic oral epithelial lesions
obtained from formalin-fixed, paraffin-embedded oral biopsy samples. There was at least
some evidence of dyskerin expression in all of the tissue samples tested (benign and
malignant), and there was wide intra- and inter-specimen variability with respect to the
intensity and extent of nucleolar staining (data not shown). Thus, differences in dyskerin
Head Neck. Author manuscript; available in PMC 2012 July 01.
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expression between normal, dysplastic, and transformed epithelium could not be reliably
quantitated. Similarly, other investigators were also unable to reliably compare dyskerin
expression in tumor tissues relative to controls through use of immunohistochemical
methods.17,20 This suggests that evaluation of dyskerin expression by
immunohistochemistry may not be of any practical use.
DKC1 and TERT mRNA expression do not correlate in OSCC or in transformed cell lines
Telomerase levels are increased in the vast majority of human cancers, including OSCC.2,3
However, while TERT and DKC1 mRNA are significantly upregulated in many of the same
cancer types, the interrelationship between DKC1 and TERT in tumor tissues is not known.
Using the same thirteen patient-derived OSCC samples and matched normal mucosal
controls described above, we found that TERT mRNA was significantly increased in 11/13
tumors relative to their respective controls (p<0.001; Figure 3C). However, there was no
correlation between the relative increase in tumor expression levels of TERT and DKC1 (r2
= 0.07, p=0.18; Figure 3D). When normalized to the expression of Tata binding protein
(TBP) mRNA, there was also no correlation between the expression of TERT and DKC1 in
the tumor tissues (r2 = 0.0089, p>>0.5; data not shown). TBP mRNA levels remained
relatively constant in all the tissue samples tested.

NIH-PA Author Manuscript

Since our cohort was limited, we proceeded to evaluate TERT and DKC1 expression levels
in a panel of 93 unique human cell lines derived from a variety of tumor types. To do this,
we analyzed one of the gene microarray datasets (NCI60 on U133A, gcRMA) available
from the open access Gene Expression Atlas.33 To our knowledge, at least five of the cell
lines in this dataset are ALT-immortalized (Supplemental Table 2). These include U2OS,
SAOS2 (osteosarcoma), Hs578T (breast adenocarcinoma), NCI H226 (non-small cell lung
carcinoma) and IOSE80 (ovarian adenocarcinoma). The vast majority of the remaining lines
are known to be telomerase-positive.
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A linear regression analysis of the log-transformed expression values revealed no correlation
(r2 = 0.0048, p>0.05) between TERT and DKC1 mRNA expression (Figure 4A). A similar
result was obtained using the Human Gene Atlas GNF1H, gcRMA dataset which is derived
from a collection of 78 normal and transformed human tissues and cell lines (not shown). As
a positive control for the in silico analysis, we also examined the relationship between
DKC1 and MYC expression. MYC promotes cell proliferation and oncogenesis, and its
amplification is common to many different tumor types.22,23 As we have previously
shown22, DKC1 and MYC expression showed significant correlation (r2=0.17, p<0.0001;
Figure 4B). Similarly, the relative levels of DKC1 and its H/ACA RNP binding partner,
NHP2/NOLA2, also strongly correlated (r2=0.26, p<0.0001; Figure 4C). There was also
significant correlation between DKC1 and MKI67 (Ki-67) expression (r2=0.11, p=0.0006;
Figure 4D). Ki-67 is required for normal ribosomal RNA synthesis and is widely used as a
marker of cell proliferation; high tumor levels of Ki-67 may be associated with poor
prognosis in some cancer types.40 There was no correlation between DKC1 and CASP3
expression (r2=0.0036, p>0.5; Figure 4E); CASP3 was randomly chosen as a factor that does
not have any known relationship to DKC1. Together, these cumulative findings suggest that
there is no overt relationship between DKC1 and TERT gene expression in human cancer.
Instead, as suggested by our in vitro data, DKC1 expression correlates with other factors that
are known to be upregulated in actively proliferating cells irrespective of telomerase status.

Discussion
The mechanisms by which DKC1 mRNA levels are increased in neoplasia as well as during
active cell proliferation remain to be clarified. Dyskerin binds to NHP2 in H/ACA RNPs and
Head Neck. Author manuscript; available in PMC 2012 July 01.
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to TERT within the telomerase complex.9,41 However, while DKC1 and NHP2 expression
showed strong correlation in the NCI60 dataset, there was no relationship between DKC1
and TERT. We have previously shown that DKC1 is a direct and conserved transcriptional
target of the MYC oncoprotein.22 MYC has also been shown to directly regulate the
transcription of TERT41 and NHP2.43 Yet, while MYC and DKC1 expression strongly
correlated, there was only weak correlation between MYC and TERT and MYC and NHP2,
respectively (not shown). We note that the in silico analysis doesn't account for posttranscriptional or post-translational modifications that may influence the expression and/or
function of either dyskerin or TERT. Nonetheless, our findings suggest that DKC1 and
TERT mRNA may be differentially regulated in tumor cells, and likely by different factors.
To that end, we have observed overexpression of DKC1 in the absence of any appreciable
changes in MYC expression (unpublished data), and TERT is also known to be regulated by
a variety of different factors.44
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TERT expression is regarded as a reliable marker for telomerase. Although recent reports
suggest TERC levels may be a rate-limiting determinant of telomerase activity under certain
conditions, amplification of TERT is the primary limiting factor for telomerase activity.
26,27,45 To that end, similar to the findings described in our current report, Cao et al26
demonstrated that DKC1 mRNA expression was upregulated 2- to 4-fold following TERTimmortalization of mammary epithelial cells, but there was no consistent correlation
between DKC1 mRNA expression and either TERT expression or telomerase activity levels.
While it remains possible that TERT may exert at least a partial influence on dyskerin
expression in telomerase-positive cells, telomerase activity is not sufficient for
immortalization of human oral keratinocytes or mammary epithelial cells; these cells also
require loss of pRB/p16INK4a cell cycle regulatory control.28,46
Defects in the pRB/p16INK4a molecular pathway are common in oral and breast
carcinogenesis28,46, and presumably are relevant in the pathogenesis of both telomerasepositive and telomerase-negative tumors. Under normal conditions, pRB binds to and
sequesters the transcription factor E2F1 thereby preventing G1 to S phase transition.
However, loss of pRB/p16INK4a regulatory control results in dysregulation of E2F1 leading
to its transcriptional overactivity47; this could be a contributing factor in dyskerin
upregulation in cancer. In support of this notion, a recent high-throughput microarray study
suggests that E2F1 may directly regulate DKC1 expression.48 Moreover, analysis of the
Gene Expression Atlas NCI60 on U133A dataset33 indicates that E2F1 and DKC1
expression do weakly correlate in transformed cells (not shown). Thus, future studies will be
needed to determine if E2F1 and/or other components of the pRB/p16INK4a pathway
regulate dyskerin.
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As an individual variable, high DKC1 mRNA levels are associated with increased tumor
aggressivity and poor prognosis in various cancer types.14-19 In addition, DKC1 expression
is upregulated in high-grade lymphomas but downregulated relative to normal controls in
indolent lymphomas.14,49,50 Moreover, a recent high-throughput study identified DKC1 as
one of only seventy genes that, collectively, constitute a gene expression profile that
strongly correlates with the development of aneuploidy and poor clinical prognosis.51
Although our sample cohort was too limited to assess statistical significance, further study is
needed to determine if the same is true for OSCC. Moreover, more detailed studies will be
needed to determine the exact mechanisms by which dyskerin contributes to tumorigenesis.
Nonetheless, our cumulative findings indicate that dyskerin expression is not dependent
upon TERT in either immortalized or transformed cells, or in patient-derived OSCCs.
However, it is apparent that mutations, targeted inhibition, or low endogenous levels of
dyskerin, respectively, do have negative impacts on normal function of the telomerase RNP,
including in tumors.2,7,8 Yet, the effect is one of only partial functional abrogation.
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Conversely, Wong et al44 demonstrated that re-introduction of wild-type dyskerin into
dyskerin-mutant cells did not revert telomerase activity to normal levels. Moreover, we have
also observed that ectopic expression of dyskerin into cells with wild-type dyskerin does not
confer additional increases in telomerase activity (unpublished data). Gu et al25 showed that
murine dyskerin could contribute to telomere maintenance through a mechanism that was
independent of telomere shortening. Thus, we cannot exclude the possibility that human
dyskerin may also play a role in telomere homeostasis in TERT- and ALT-immortalized
cells that can be uncoupled from the role of the protein within the telomerase complex.
Alternatively, it is possible that dysregulation of dyskerin may also perturb other vital
cellular functions.
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Emerging evidence implicates aberrant ribosome biogenesis and function in neoplastic
transformation and progression.13 Whether upregulation of dyskerin contributes to
alterations in ribosome synthesis and/or activity is currently unknown. It has also been
suggested that high levels of dyskerin may be broadly disruptive to the assembly of H/ACA
snoRNPs.45 To that end, one of dyskerin's obligate binding partners, NHP2, is also
upregulated in neoplasia; high levels of this factor are associated with poor prognosis in lung
squamous cell carcinoma and colorectal adenocarcinoma.19,43 Like dyskerin, NHP2 is also
essential for the assembly and maturation of H/ACA RNPs, and is needed for normal rRNA
processing and telomere maintenance; NHP2 is also a telomerase component.9 We have
shown that DKC1 and NHP2 mRNA expression strongly correlate in transformed cell lines
(Figure 4C). Therefore, it is possible that dysregulation of H/ACA RNP biogenesis,
irrespective of the mechanism, may be broadly disruptive to normal cellular homeostasis and
that such alterations may contribute to tumorigenesis. This will require more detailed
investigation.
Finally, it is possible that dyskerin may contribute to the regulation of other important
molecular processes beyond those for which the protein has already been implicated in. To
that end, we have recently shown that acute loss of dyskerin function impairs the
accumulation of a specific subset of microRNAs.52 MicroRNAs are a class of small noncoding RNAs that directly regulate post-transcriptional gene expression.53 MicroRNAs
regulate a wide array of cellular functions including cell proliferation; a number of
microRNAs have been implicated in tumorigenesis.53 Thus, future studies will be needed to
determine if dyskerin contributes to normal and tumor cell growth through regulation of
miRNA-mediated post-transcriptional gene expression.
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Figure 1. Upregulation of dyskerin in immortalized oral keratinocytes is not dependent upon
TERT
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A, OKF6-TERT2 cells were transfected with either 10 μM TERT antisense DNA
oligonucleotide (ANTI) or a control, non-specific oligonucleotide (CTRL). Twenty-four
hours later, relative telomerase activity levels were assessed by quantitative RT-PCR and
normalized to telomerase levels in the untransfected OKF6-TERT2 cells. B, TERT / β-actin
and DKC1 / β-actin expression was normalized to levels of the respective transcripts in the
OKF6-TERT2 cells. The solid bars represent the mean values of four transfections
conducted in one representative experiment; error bars denote the standard deviations. C, A
qualitative TRAP assay was used to measure telomerase activity in exponentially-growing
OKF6-TERT2 and OKF6-Δp53D1 cells. The characteristic laddering effect was observed in
the OKF6-TERT2 and other telomerase-expressing cells, including UM-SCC1 oral cancer
cells and a control cell pellet included with the kit, but not in the ALT-immortalized OKF6Δp53D1 cells. The internal control served as a control for the PCR reaction. D, DKC1
mRNA expression was assessed by quantitative RT-PCR in OKF6, OKF6-Δp53D1 and
OKF6-TERT2 cells. E, Dyskerin protein levels were quantitated relative to β-actin using
NIH Image J.
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Figure 2. Dyskerin expression correlates with the rate of cell proliferation
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A, Fold increase in cell proliferation rates were determined by normalizing the relative
WST-1 absorbance for each of the respective cell lines to those measured on the first day
after plating. Error bars denote standard deviation from triplicate wells for each time point.
Experiments were repeated twice with similar results. B, Cells were harvested in log growth
phase (three days after initial plating) and total cell lysates were subjected to Western blot.
Dyskerin was increased in the TERT-immortalized cells relative to their parental cells, and
even more so in the transformed cells. For comparison purposes, dyskerin expression was
also examined in the transformed squamous epithelial cell lines, SCC-10B and SCC-22B. C,
Dyskerin expression was normalized to actin, and then compared to the fold increase in
WST-1 absorbance three days after initial plating. A linear regression analysis showed
strong correlation (r2 = 0.927, p < 0.001) between relative dyskerin levels and cell
proliferation. D, Dyskerin expression was reduced in contact-inhibited OKF6 and OKF6TERT2 cells (100%) relative to the exponentially growing cells (50%-60% confluent).
Except where indicated, all protein lysates were obtained from actively proliferating cells. E,
Cell cycle distribution of OKF6-TERT2 cells at 60% and 100% confluency. OKF6 cells
showed a similar profile (not shown).
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Figure 3. DKC1 and TERT mRNA expression do not correlate in patient-derived OSCC

A, Box plot illustrating DKC1 upregulation in OSCC (N=49) relative to matched normal
controls (N=16; p<0.023). Data represent the average relative signals for DKC1 from two
independent arrays.31 B, DKC1 mRNA levels were significantly (p<0.03) increased (*) in
9/13 OSCC (light grey bars) relative to patient-matched normal mucosal controls (white
bars). C, TERT mRNA levels were significantly (p<0.001) increased (*) in 11/13 OSCC
(dark grey bars) relative to the controls (white bars). D, There was no correlation between
the relative fold increase in TERT and DKC1 mRNA expression in the tumors. Using an
arbitrary threshold of a 2-fold increase in tumor mRNA expression relative to the matched
normal control (horizontal line), 10/11 high TERT expressing tumors surpassed the
threshold, while only 4/9 high DKC1 expressing tumors were increased beyond this
threshold. DKC1 and TERT mRNA levels were measured relative to TBP) mRNA by
quantitative RT-PCR using the 2−ΔΔCt method. N = normal, T = tumor.
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Figure 4. DKC1 and TERT mRNA expression do not correlate in transformed human cell lines

A, A linear regression analysis of the log-transformed expression values revealed no
correlation (r2 = 0.019, p=0.21) between TERT and DKC1 mRNA expression. B, DKC1 and
MYC expression showed significant correlation (r2=0.17, p<0.0001). C, Relative levels of
DKC1 and its H/ACA snoRNP binding partner, NHP2, also strongly correlated (r2=0.26,
p<0.0001). D, DKC1 and the cell proliferation marker MKI67 also showed correlation
(r2=0.11 p=0.0006). E, There was no correlation between DKC1 and CASP3 expression
(r2=0.0036, p>0.5); CASP3 was randomly chosen as a factor that does not have any known
relationship to DKC1. The raw data and corresponding log transformations for each of the
genes are listed in Supplemental Table 2.
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